Summary of the 6th annual bladder cancer think tank: New directions in urologic research

Robert S. Svatek, Jonathan E. Rosenberg, Matthew D. Galsky, Cheryl T. Lee, David M. Latini, Bernard H. Bochner, Alon Z. Weizer, Andrea B. Apolo, Srikala S. Sridhar, Ashish M. Kamat, Donna Hansel, Thomas W. Flaig, Norm D. Smith, Yair Lotan

Research output: Contribution to journalArticle

4 Scopus citations


The 6th Annual Bladder Cancer Think Tank brought together a multidisciplinary group of clinicians, researchers, and representatives from the National Cancer Institute and Industry in an effort to advance bladder cancer research efforts. This year's meeting comprised panel discussions and research involving 5 separate working groups, including the Survivorship, Clinical Trials, Standardization of Care, Data Mining, and Translational Science working groups. In this manuscript, the accomplishments and objectives of the working groups are summarized. Notable efforts include: (1) the development of a survivorship care plan for early and late-stage bladder cancer; (2) the development of consensus criteria for eligibility and endpoints for bladder cancer clinical trials; (3) an improved understanding of current practice patterns regarding the use of perioperative chemotherapy in an effort to standardize care; (4) creation of a comprehensive handbook to assist researchers with developing bladder cancer databases; and (5) identification of response to therapy of high-grade non muscle invasive disease through a collaborative exchange of expertise and resources.

Original languageEnglish (US)
Pages (from-to)968-973
Number of pages6
JournalUrologic Oncology: Seminars and Original Investigations
Issue number7
StatePublished - Oct 2013


ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

Svatek, R. S., Rosenberg, J. E., Galsky, M. D., Lee, C. T., Latini, D. M., Bochner, B. H., Weizer, A. Z., Apolo, A. B., Sridhar, S. S., Kamat, A. M., Hansel, D., Flaig, T. W., Smith, N. D., & Lotan, Y. (2013). Summary of the 6th annual bladder cancer think tank: New directions in urologic research. Urologic Oncology: Seminars and Original Investigations, 31(7), 968-973.